Postmarketing surveillance

Results: 136



#Item
1COMMISSION OF THE EUROPEAN COMMUNITIES  Brussels, 10 December 2008 SECVolume I

COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 10 December 2008 SECVolume I

Add to Reading List

Source URL: www.myereport.eu

Language: English - Date: 2015-11-08 06:14:30
2IMDRF Presentation - WHO update

IMDRF Presentation - WHO update

Add to Reading List

Source URL: www.imdrf.org

Language: English - Date: 2015-09-07 20:17:35
3IMDRF Presentation - Update on WHO work

IMDRF Presentation - Update on WHO work

Add to Reading List

Source URL: www.imdrf.org

Language: English - Date: 2016-03-30 00:21:33
4Microsoft Word - Volume IX ENdoc

Microsoft Word - Volume IX ENdoc

Add to Reading List

Source URL: ec.europa.eu

Language: English - Date: 2013-10-09 08:59:58
5Kyrgyzstan Assessment of Pharmaceutical Data Disclosure  Disclosure Status of Pharmaceutical Sector Data Part of Component 1 of the MeTA Baseline Assessments  Kyrgyz Republic

Kyrgyzstan Assessment of Pharmaceutical Data Disclosure Disclosure Status of Pharmaceutical Sector Data Part of Component 1 of the MeTA Baseline Assessments Kyrgyz Republic

Add to Reading List

Source URL: www.medicinestransparency.org

Language: English - Date: 2013-01-23 03:05:36
6Web-based Intensive Monitoring: a patient based pharmacovigilance tool

Web-based Intensive Monitoring: a patient based pharmacovigilance tool

Add to Reading List

Source URL: www.lareb.nl

Language: English
7MEDICINE & DEVICE SURVEILLANCE CRE Newsletter Welcome to the first Medicine and Device Surveillance CRE newsletter.

MEDICINE & DEVICE SURVEILLANCE CRE Newsletter Welcome to the first Medicine and Device Surveillance CRE newsletter.

Add to Reading List

Source URL: unisa.edu.au

Language: English - Date: 2014-04-29 22:06:12
82009  PHARMACOVIGILANCE POLICY This document and its contents are the confidential property of Biocon Ltd. It should not be copied, reproduced, modified, altered, or circulated to any third party, in any form or media, w

2009 PHARMACOVIGILANCE POLICY This document and its contents are the confidential property of Biocon Ltd. It should not be copied, reproduced, modified, altered, or circulated to any third party, in any form or media, w

Add to Reading List

Source URL: www.biocon.com

Language: English - Date: 2009-11-12 18:24:13
9Adverse drug reactions.indd

Adverse drug reactions.indd

Add to Reading List

Source URL: www.nets.nihr.ac.uk

Language: English - Date: 2014-01-20 10:24:44
10Federal Register / Vol. 80, NoWednesday, April 15, Notices document (see DATES). FDA will forward all nominations to the organizations expressing interest in participating in the selection process for the c

Federal Register / Vol. 80, NoWednesday, April 15, Notices document (see DATES). FDA will forward all nominations to the organizations expressing interest in participating in the selection process for the c

Add to Reading List

Source URL: www.gpo.gov

Language: English - Date: 2015-04-15 10:56:31